Health

111, Inc. Launches New Video Interview Series on China's Healthcare Landscape

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- Starting in August 2019, 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, will launch "111 Insight", a video series on the development of the healthcare industry inChina. The series is produced b...

2019-08-15 20:21 9376

United Imaging Announces First U.S. Clinical Installation and Patient Scans of the uEXPLORER Total-Body PET/CT System

HOUSTON, Aug. 15, 2019 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, today announced that its uEXPLORER total-body PET/CT system is now in use. United Imaging developed uEXPLORER in partnership with the EXPLORER Consortium led bySimon Che...

2019-08-15 20:00 2092

China Pharma Holdings, Inc. Reports Second Quarter 2019 Financial Results

HAIKOU, China, Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2019-08-15 18:30 8110

111, Inc. Announces Second Quarter 2019 Unaudited Financial Results and US$10 Million Share Repurchase Program

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading integrated online and offline healthcare platform in China, today announced its unaudited financial results for the second quarter endedJune 30, 2019 and US$10 million share repurchase program. ...

2019-08-15 16:53 7473

CStone Pharmaceuticals Reports First Half 2019 Financial Results

SHANGHAI, Aug. 15, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616), a leading biopharmaceutical company focused on developing and commercializing innovative immuno-oncology therapies and molecularly-targeted drugs for the treatment of cancer, today released its recent business ...

2019-08-15 15:31 6002

China Jo-Jo Drugstores Reports First Quarter 2020 Financial Results

HANGZHOU, China, Aug. 14, 2019 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ CM: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider inChina, today announced i...

2019-08-14 21:00 7528

CHJ Entrepreneurship and Innovation Competition 2019 Held in Shanghai

SHANGHAI, Aug. 13, 2019 /PRNewswire/ -- The semi-final of CHJ Entrepreneurship and Innovation Competition 2019 for small and medium-sized companies was held on August 9. The competition aims to discover and cultivate excellent projects and teams, to promote innovation and entrepreneurship inChina....

2019-08-13 13:36 2313

CStone announces first patient dosed in China with BLU-667 for the global Phase I registrational study

SUZHOU, China, Aug. 13, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announces the dosing of the first patient inChina for the Phase I registrational study of BLU-667, which was discovered by the company's partner Blueprint Medicines. This clinical trial is a part of t...

2019-08-13 12:21 6948

New Review Suggests Normal Use of Electronic Cigarettes is Unlikely to Raise Significant Health Concerns

Lack of Clear Communications About E-Cigarettes Could Lead to More Deaths Due to Combustible Cigarette Smoking WELLINGTON, New Zealand, Aug. 13, 2019 /PRNewswire/ -- Smokers should be confident that vaping with e-cigarettes is much less harmful to the lungs than smoking cigarettes, according to ...

2019-08-13 05:00 2524

New Publication Shows Different Result of Risk Classification between GenesWell BCT and Oncotype DX in Breast Cancer Patients 50 Years Old or Younger.

SEOUL, South Korea, Aug. 12, 2019 /PRNewswire/ -- Gencurix, Inc., a company dedicated in development and market of innovative molecular diagnostics, announced the publication of a new study onFrontiers in Oncology comparing GenesWell™ BCT, a prognostic multigene test, with Genomic Health's Oncoty...

2019-08-12 21:00 2480

China SXT Pharmaceuticals, Inc. Receives New Pharmaceutical GMP Certificate

TAIZHOU, China, Aug. 12, 2019 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), announced to...

2019-08-12 20:00 7093

Samsung BioLogics Implements Large Scale N-1 Perfusion for Commercial Application

INCHEON, South Korea, Aug. 12, 2019 /PRNewswire/ -- Samsung BioLogics (SBL) has successfully performed N-1 (3,000L) perfusion with Alternating Tangential Flow (ATF) device to supply the 15,000L commercial production process in the Plant 3 facility at its manufacturing site in Songdo, S. Korea rec...

2019-08-12 19:00 2083

The iQ Group Global named one of Australia's Top 5 Most Innovative Companies 2019

SYDNEY, Aug. 9, 2019 /PRNewswire/ -- The iQ Group Global  is honoured to be recognised as one of Australia andNew Zealand's Top 5 Most Innovative Companies by The Australian Financial Review and BOSS Magazine in its relentless pursuit to create the medicines of tom...

2019-08-09 18:46 2313

EnGeneIC Wins Innovation Award from Australian Financial Review

Named Most Innovative Healthcare Company of 2019 for its Nanocell Platform for Targeted Cyto-Immunotherapy in Cancer Treatment NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targe...

2019-08-09 12:49 1900

Volition Forms Texas-Based Veterinary Subsidiary and Appoints its Chief Executive Officer

AUSTIN, Texas, Aug. 8, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the recent formation of a subsidiary, Volition Veterinary Diagnostics Development LLC ("Volition Veterinary"), and the appointment of animal health expertNathan Dewsbury as its Chief ...

2019-08-08 20:30 7196

111 Wins 2019 China Healthcare Industry Best Corporate Award

SHANGHAI, Aug. 7, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, announced its winningof the 2019 China Healthcare Industry Best Company Award at the 4th China Healthcare Industry Summit held in Beijing. The Award...

2019-08-08 08:00 7280

VolitionRx Limited Schedules Second Quarter 2019 Earnings Conference Call and Business Update

AUSTIN, Texas, Aug. 7, 2019 /PRNewswire/ -- VolitionRx Limited (NYSE American: VNRX) today announced it will host a conference call onTuesday, August 13 at 8:30 a.m. Eastern time to discuss its financial and operating results for the second quarter of 2019 in addition to providing a business upd...

2019-08-07 20:45 7437

CStone to Build Global R&D Headquarters and Industrialization Base in the Suzhou Industrial Park

SUZHOU, China, Aug. 7, 2019 /PRNewswire/ -- The signing ceremony for CStone Pharmaceuticals' ("CStone") (HKEX: 2616) Global R&D Headquarters and Industrialization Base ("the Project") took place in Suzhouon August 6. The event marks the building of yet another state-of-the-art research and devel...

2019-08-07 14:47 7807

EDAN Announces Relocation and Expansion of Its US Operation Hub

SAN DIEGO, Aug. 6, 2019 /PRNewswire/ -- EDAN Diagnostic, Inc. (ED), serving as the American operation hub of EDAN Instruments, Inc. - a healthcare company and medical device manufacturer, announced an office relocation and expansion. The new address is 9918 Via Pasar,San Diego, CA 92126. This bra...

2019-08-06 23:17 3049

China Biologic Reports Financial Results for the Second Quarter of 2019

--2Q19 Total Sales Up 12.7% YoY in USD terms, or 20.4% YoY in RMB terms; Net Income Up 45.5% YoY to$41.6 Million; Non-GAAP Adjusted Net Income Up 29.1% YoY in RMB terms-- --1H19 Total Sales Up 14.0% YoY in USD terms, or 21.3% YoY in RMB terms; Net Income Up 31.7% YoY to$79.3 Million; Non-GAA...

2019-08-06 04:30 8343